Charles Schwab Investment Management Inc. lessened its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD – Free Report) by 15.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,158,240 shares of the company’s stock after selling 209,105 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Pediatrix Medical Group were worth $15,196,000 at the end of the most recent reporting period.
Several other institutional investors have also recently bought and sold shares of the business. Rubric Capital Management LP raised its position in Pediatrix Medical Group by 1.5% in the 3rd quarter. Rubric Capital Management LP now owns 8,275,000 shares of the company’s stock valued at $95,907,000 after purchasing an additional 125,000 shares during the last quarter. State Street Corp raised its position in Pediatrix Medical Group by 1.4% in the 3rd quarter. State Street Corp now owns 3,540,791 shares of the company’s stock valued at $41,038,000 after purchasing an additional 50,597 shares during the last quarter. Pacer Advisors Inc. bought a new position in Pediatrix Medical Group in the 4th quarter valued at $35,492,000. Geode Capital Management LLC raised its position in Pediatrix Medical Group by 2.4% in the 3rd quarter. Geode Capital Management LLC now owns 1,936,751 shares of the company’s stock valued at $22,452,000 after purchasing an additional 45,155 shares during the last quarter. Finally, Weiss Asset Management LP raised its position in Pediatrix Medical Group by 50.5% in the 3rd quarter. Weiss Asset Management LP now owns 912,818 shares of the company’s stock valued at $10,580,000 after purchasing an additional 306,143 shares during the last quarter. Institutional investors own 97.71% of the company’s stock.
Pediatrix Medical Group Stock Down 0.8 %
Shares of Pediatrix Medical Group stock opened at $14.12 on Friday. The company has a quick ratio of 1.42, a current ratio of 1.60 and a debt-to-equity ratio of 0.81. Pediatrix Medical Group, Inc. has a 12 month low of $6.62 and a 12 month high of $17.67. The business has a fifty day simple moving average of $14.28 and a 200 day simple moving average of $13.49. The stock has a market cap of $1.21 billion, a PE ratio of -11.76, a price-to-earnings-growth ratio of 1.74 and a beta of 1.49.
Wall Street Analyst Weigh In
Several brokerages have issued reports on MD. Macquarie began coverage on Pediatrix Medical Group in a research report on Monday, December 16th. They issued an “outperform” rating and a $18.00 price objective for the company. UBS Group boosted their target price on Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a “neutral” rating in a research report on Friday, February 21st. StockNews.com upgraded Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research report on Wednesday, January 22nd. Finally, Truist Financial boosted their target price on Pediatrix Medical Group from $15.00 to $18.00 and gave the stock a “hold” rating in a research report on Friday, February 21st. Four research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $17.08.
View Our Latest Stock Report on MD
Pediatrix Medical Group Profile
Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.
Featured Stories
- Five stocks we like better than Pediatrix Medical Group
- How to Plot Fibonacci Price Inflection Levels
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- Overbought Stocks Explained: Should You Trade Them?
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Want to see what other hedge funds are holding MD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pediatrix Medical Group, Inc. (NYSE:MD – Free Report).
Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.